- An open-label, randomized, controlled, 4-week comparative clinical trial of barnidipine hydrochloride, a calcium-channel blocker, and benazepril, an angiotensin-converting enzyme inhibitor, in Chinese patients with renal parenchymal hypertension. Chen, X., Zheng, F., Chen, P., Tang, L., Wei, R., Yu, Y., Su, Y., Kikkawa, T., Yamamoto, M. J. Int. Med. Res. (2006)